The University of Chicago Header Logo

Search Results (91)

More Search Options
MatchTypeWhy
Infectious complications of car T-cell therapy: A longitudinal risk model.Academic Article Why?
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.Academic Article Why?
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.Academic Article Why?
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.Academic Article Why?
Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.Academic Article Why?
Advances in CAR T-Cell Therapy for Aggressive B-NHL.Academic Article Why?
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy.Academic Article Why?
Current Status of CAR T Cell Therapy for Leukemias.Academic Article Why?
Kline, Justin P.Person Why?
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.Academic Article Why?
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.Academic Article Why?
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.Academic Article Why?
Riedell, PeterPerson Why?
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.Academic Article Why?
Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy.Academic Article Why?
Per Page    Page  of 7last Nextnext
Prev
Search Criteria
  • CAR
  • T
  • cell therapy
Filter by Type
_
Click "Why?" to see why an item matched the search.